ArticleArthritis care & research2024

Frailty and Risk of Serious Infections in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted-Synthetic Disease-Modifying Antirheumatic Drugs.

Namrata Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.